SEC Form 4 · accession 0001493152-18-009769

ONCOSEC MEDICAL Inc · ONCS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).

Reporting owner

Director

Period of report

Jun 15, 2018

Accepted (ET)

Jul 6, 2018 · 4:40 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001444307

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Jun 15, 2018	M	125,000	—	A	355,702	D
Common Stock^F1	Jun 15, 2018	M	150,000	—	A	505,702	D
Common Stock^F1	Jun 15, 2018	M	200,000	—	A	705,702	D
Common Stock^F2	Jun 18, 2018	S	28,145	$1.386	D	677,557	D
Common Stock^F2	Jun 19, 2018	S	9,310	$1.364	D	668,247	D
Common Stock^F2	Jun 20, 2018	S	55,585	$1.422	D	612,662	D
Common Stock^F2	Jun 21, 2018	S	11,035	$1.401	D	601,627	D
Common Stock^F2	Jun 22, 2018	S	14,976	$1.418	D	586,651	D
Common Stock^F2	Jun 25, 2018	S	1,021	$1.405	D	585,630	D
Common Stock^F2	Jun 26, 2018	S	23,820	$1.398	D	561,810	D
Common Stock^F2	Jun 27, 2018	S	17,480	$1.374	D	544,330	D
Common Stock^F2	Jun 28, 2018	S	7,882	$1.401	D	536,448	D
Common Stock^F2	Jun 29, 2018	S	5,401	$1.38	D	531,047	D
Common Stock^F2	Jul 5, 2018	S	45,785	$1.312	D	485,262	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Restricted Stock Units^F1	—	Jun 15, 2018	M	125,000	D	Mar 4, 2019	Mar 4, 2019	Common Stock	125,000	D
Restricted Stock Units^F1	—	Jun 15, 2018	M	150,000	D	Mar 29, 2020	Mar 29, 2020	Common Stock	150,000	D
Restricted Stock Units^F1	—	Jun 15, 2018	M	200,000	D	Nov 4, 2018	Nov 4, 2018	Common Stock	200,000	D

F1Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
F2Sale to cover taxes on restricted stock unit vesting.